Drug test

Federal Drug Testing Regulations Spark Surge in Demand for Oral Fluid Testing

Retrieved on: 
Thursday, September 21, 2023
Urine, DOT, SR, Drug test, Laboratory, Rail transport by country, Privacy, HHS, Pharmaceutical industry

EVANSVILLE, Ind., Sept. 21, 2023 /PRNewswire/ -- A recent change in federal drug testing regulations is expected to create a surge in demand for oral fluid drug testing. eRAMx Live Remote Testing is prepared to meet the needs of companies requiring oral fluid testing for the first time.

Key Points: 
  • EVANSVILLE, Ind., Sept. 21, 2023 /PRNewswire/ -- A recent change in federal drug testing regulations is expected to create a surge in demand for oral fluid drug testing.
  • eRAMx Live Remote Testing is prepared to meet the needs of companies requiring oral fluid testing for the first time.
  • Effective June 1, 2023, the Department of Transportation (DOT) has authorized oral fluid testing for the first time, marking a significant shift away from urine-only drug testing policies.
  • As employers transition from urine to oral fluid testing, we are proud to provide the most advanced, streamlined remote testing platform available"

Global Employment Screening Market Insights & Forecast Report 2022-2026 with Potential Impacts of COVID-19 - ResearchAndMarkets.com

Retrieved on: 
Wednesday, January 25, 2023
COVID-19, Health, Telecom, Travel, Government, Finance, Hospitality, Check (chess), Artificial intelligence, Workforce, LANCK Telecom, Health care, Drug test, Society for Accessible Travel & Hospitality, Growth, US, Employment, Telephone numbers in Hungary, Video game, Mobile phone

The "Global Employment Screening Market (Verification, Background Screening & Drug Testing): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Employment Screening Market (Verification, Background Screening & Drug Testing): Insights & Forecast with Potential Impact of COVID-19 (2022-2026)" report has been added to ResearchAndMarkets.com's offering.
  • In 2021, the dominant share of global employment screening market was held by IT & Telecom sector.
  • The global employment screening market can be segmented into the following regions: North America, Europe, Asia Pacific, Middle East & Africa, and South America.
  • The report provides a comprehensive analysis of the global employment screening market.

Global Employment Screening Market Report 2022: A $5.75 Billion Market by 2026 Featuring ADP, HireRight, Sterling, First Advantage, Accurate Background, & Checkr

Retrieved on: 
Thursday, January 26, 2023
Artificial intelligence, Travel, Workforce, Employment, Telecom, US, COVID-19, Finance, Growth, Hospitality, Society for Accessible Travel & Hospitality, Telephone numbers in Hungary, Government, LANCK Telecom, Drug test, Check (chess), Health care, Video game, Mobile phone

The global employment screening market is forecasted to reach US$5.75 billion in 2026, experiencing growth at a CAGR of 5.51% during the period spanning from 2022 to 2026.

Key Points: 
  • The global employment screening market is forecasted to reach US$5.75 billion in 2026, experiencing growth at a CAGR of 5.51% during the period spanning from 2022 to 2026.
  • In 2021, the dominant share of global employment screening market was held by IT & Telecom sector.
  • The global employment screening market can be segmented into the following regions: North America, Europe, Asia Pacific, Middle East & Africa, and South America.
  • The report provides a comprehensive analysis of the global employment screening market.

Global Employment Screening Market (2021 to 2025) - Improved Regulatory Compliance is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Monday, January 17, 2022
Professional Services, Other Professional Services, Government, Financial services, Telecom, Society for Accessible Travel & Hospitality, Check (chess), Drug test, Population, Health care, ADP, Intelligence, Hospitality, Urban, Employment, Intec Telecom Systems, Workforce, HireRight, Video game, Growth

The global employment screening market can be categorized into the following sectors: IT & Telecom, Manufacturing, Retails, Banking, Financial Services & Insurance, Travel & Hospitality, Government Agencies, Healthcare and Others.

Key Points: 
  • The global employment screening market can be categorized into the following sectors: IT & Telecom, Manufacturing, Retails, Banking, Financial Services & Insurance, Travel & Hospitality, Government Agencies, Healthcare and Others.
  • In 2020, the dominant share of the global employment screening market was held by the IT & Telecom sector.
  • The global employment screening market can be segmented into the following regions: North America, Europe, Asia Pacific, Middle East & Africa, and South America.
  • In 2020, the dominant share of the global employment screening market was held by North America.

The Worldwide Employment Screening Industry is Expected to Reach $5.45 Billion in 2025

Retrieved on: 
Monday, January 17, 2022
CAGR, Government, Financial services, Telecom, Society for Accessible Travel & Hospitality, Check (chess), Drug test, COVID-19, US, Population, Growth, Health care, ADP, Intelligence, Hospitality, Urban, Employment, Intec Telecom Systems, Workforce, HireRight, Ridesharing company, Video game

The global employment screening market is forecasted to reach US$5.45 billion in 2025, experiencing growth at a CAGR of 5.50% during the period spanning from 2021 to 2025.

Key Points: 
  • The global employment screening market is forecasted to reach US$5.45 billion in 2025, experiencing growth at a CAGR of 5.50% during the period spanning from 2021 to 2025.
  • In 2020, the dominant share of the global employment screening market was held by the IT & Telecom sector.
  • The global employment screening market can be segmented into the following regions: North America, Europe, Asia Pacific, Middle East & Africa, and South America.
  • The U.S. employment screening market can be segmented into three services: Verification, Background Screening, and Drug Testing.

Worldwide Immunohistochemistry Industry to 2028 - Rising Incidences of Chronic and Infectious Diseases is Driving Growth - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 30, 2021
Biotechnology, Pharmaceutical, Health, Growth, Equipment, COVID-19, Death, AHA, Disease, Population, Drug test, Hepatitis, Degenerative disease, CAGR, Investment, CDC, Cardiovascular disease, NCHS, Geography, Cancer, Viral Research and Diagnostic Laboratories, IHC, Fever Dream, Mortality, Diabetes, European, Medical statistics, Diagnosis, Joint United Nations Programme on HIV/AIDS, AVERT, Antibody, Immunohistochemistry, HIV, Obesity, Korea Disease Control and Prevention Agency, Stroke, Prevalence, Cerebrovascular disease, Incidence, Adult, AIDS, HIV/AIDS, Hospital, Biotechnology, Antigen, American Heart Association, APAC, Research, UNAIDS, Time, Moyamoya disease, Center, National Center for Health Statistics, Union, CVD, Industry, Overweight, Fine chemical, Vaccine, Fast food, Marketing, Kits, EU

Rising incidence of chronic and infectious diseases, increasing geriatric population, and rising R&D investments by biotechnology and biopharmaceutical companies are the key factors driving the market.

Key Points: 
  • Rising incidence of chronic and infectious diseases, increasing geriatric population, and rising R&D investments by biotechnology and biopharmaceutical companies are the key factors driving the market.
  • Immunohistochemistry (IHC) refers to an important application of monoclonal and polyclonal antibodies for tissue determination and distribution of antigens of a particular disease.
  • Immunohistochemistry helps diagnose chronic medical conditions like obesity, cancer, diabetes, heart disease, and stroke.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

InCheck Named on 2021 HRO Today's Baker's Dozen List for Enterprise Pre-Employment Background Screening Providers During an Exciting Time of Company Growth

Retrieved on: 
Tuesday, November 23, 2021
Quality of service, PBSA, Drug test, Chief compliance officer, Quality, Baker, OHS, Entrepreneurship, Organization, HRO, Basic Occupational Health Services, Human resource management, Multimedia, Employment, Management, Online shopping

MILWAUKEE, Nov. 23, 2021 /PRNewswire/ -- InCheck, Inc., a full-service background screening company located in southeastern Wisconsin, is pleased to announce its second consecutive year of ranking on HRO Today's Baker's Dozen Customer Satisfaction Ratings for screening providers .

Key Points: 
  • MILWAUKEE, Nov. 23, 2021 /PRNewswire/ -- InCheck, Inc., a full-service background screening company located in southeastern Wisconsin, is pleased to announce its second consecutive year of ranking on HRO Today's Baker's Dozen Customer Satisfaction Ratings for screening providers .
  • When the results were in, InCheck achieved the Baker's Dozen Enterprise ranking in several categories: Breadth of Service, Size of Deal (e.g., organizational capacity for large programs), Quality of Service, and Overall Score.
  • "We are incredibly pleased to make this year's list of enterprise background screening providers.
  • She is Professional Background Screening Association (PBSA) certified and brings almost ten years of experience in the background screening industry.

The Worldwide Rapid Microbiology Testing Industry is Expected to Reach $6.7 Billion by 2020 - ResearchAndMarkets.com

Retrieved on: 
Friday, July 23, 2021
Retail, Science, Other Science, Food, Beverage, Doping in sport, Drug test, Tests, Workplace, Academic disciplines, Compound annual growth rate, Articles, Clinical medicine

The global rapid microbiology testing market is projected to reach USD 6.7 billion by 2026 from USD 4.2 billion in 2021, at a CAGR of 9.4% during the forecast period.

Key Points: 
  • The global rapid microbiology testing market is projected to reach USD 6.7 billion by 2026 from USD 4.2 billion in 2021, at a CAGR of 9.4% during the forecast period.
  • The reagents and kits segment accounted for the highest growth rate in the rapid microbiology testing market, by product, during the forecast period
    The rapid microbiology testing market is segmented instruments, reagents and kits and consumables based on product.
  • In 2020, the reagents and kits segment accounted for the highest growth rate in the rapid microbiology testing market.
  • Based on applications, the rapid microbiology testing market is segmented into clinical disease diagnosis, food and beverage testing, pharmaceutical and biological drug testing, environmental testing, cosmetics and personal care products testing, research applications and other applications.

Insights on the Drug Screening Laboratory Global Market to 2026 - Featuring Abbott Laboratories, Alere and Siemens Among Others - ResearchAndMarkets.com

Retrieved on: 
Friday, July 9, 2021
Health, General Health, Doping in sport, Drug test, Tests, Workplace, Clinical medicine, Articles, Human behavior

The study on drug screening laboratory market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.

Key Points: 
  • The study on drug screening laboratory market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2018 to 2026.
  • The report on drug screening laboratory market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global drug screening laboratory market over the period of 2018 to 2026.
  • Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global drug screening laboratory market over the period of 2018 to 2026.
  • The global drug screening laboratory market is segmented on the basis of sample type, and end user.

Cannabix Technologies Granted Cannabis Drug Detection Device Canadian Patent, Delivers THCBA to US Clinic

Retrieved on: 
Tuesday, July 6, 2021
Psychoactive drugs, Drugs, Appetite stimulants, Entheogens, Euphoriants, Clinical medicine, Cannabis, Alcohol law, Tetrahydrocannabinol, Drug test, Driving under the influence, Cannabinol

Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of 9-tetrahydrocannabinol (THC) - the psychoactive component of marijuana that causes impairment.

Key Points: 
  • Cannabix Technologies is on the forefront in research and development to create point-of-care breath testing technologies for the detection of 9-tetrahydrocannabinol (THC) - the psychoactive component of marijuana that causes impairment.
  • The Company also reports that in June it delivered its THC Breath Analyzer (THCBA) to a clinic in the Northwestern, U.S. for beta testing.
  • The collaborating clinic has a robust drug testing operation and is one of the top drug testing providers to employers within its respective state.
  • Cannabix Technologies Inc. is a developer of marijuana breathalyzer technologies for law enforcement and the workplace.